Skip to main content
. 2019 Sep 3;36(10):2723–2743. doi: 10.1007/s12325-019-01073-7

Table 4.

Statin intolerance symptom severity and bothersomeness ratings

Symptoms All patients (n = 65)
Symptom severity Symptom bothersomeness
n Mean score (SD) [range] n Mean score (SD) [range]
Non-muscle-related pain and discomfort
 Arthritis and bone symptoms
  Bone or joint ache 10 7.7 (0.9) [6–9] 4 7.8 (2.1) [6–10]
  Bone or joint pain 3 5.7 (2.9) [4–9] 26 7.7 (2.1) [3–10]
  Stiff or cracking joints 3 6.7 (3.5) [3–10] 2 10.0 (0) [10]
  Soreness 5 7.8 (2.0) [6–10] 7 7.1 (3.0) [3–10]
  Tenderness 3 7.0 (1.7) [5–8] 7 7.7 (1.3) [6–10]
 Bone or joint weakness
  Joint weakness 0 NA 1 8.0
 Burning and stinging
  Burning 2 8.5 (2.1) [7–10] 1 9.0
  Stinging 0 NA 1 8.0
 Headache 4 7.3 (2.1) [5–10] 5 6.2 (2.2) [5–10]
 Non-muscle neck or back pain 0 NA 6 8.2 (3.0) [3–10]
 Non-muscle pain or discomfort 21 7.4 (2.0) [2–10] 14 7.6 (1.6) [5–10]
Muscle-related pain or discomfort
 Muscle ache 23 7.4 (2.1) [3–10] 28 6.4 (2.0) [2–10]
 Muscle burning 0 NA 1 7.0
 Muscle cramps 25 7.4 (2.2) [2–10] 26 7.0 (2.5) [2–10]
 Muscle tears 1 10.0 2 9.0 (1.4) [8–10]
 Soreness and tenderness
  Soreness 12 8.1 (1.8) [5–10] 14 6.8 (1.9) [4–10]
  Tenderness 8 8.3 (1.7) [5–10] 7 7.0 (1.9) [4–10]
 Muscle pain or discomfort 39 7.2 (2.3) [3–10] 26 7.1 (2.4) [1–10]
Non-pain muscle-related symptoms
 Muscle weakness
  Muscle fatigue 13 7.7 (2.6) [1–10] 13 7.1 (2.2) [4–10]
  Muscle heaviness 18 7.0 (2.5) [1–10] 18 6.9 (2.2) [2–10]
  Muscle weakness 19 7.4 (1.9) [5–10] 26 7.0 (2.0) [2–10]
 Muscle stiffness 19 7.1 (2.5) [3–10] 28 6.4 (2.2) [1–10]
 Muscle tingling 1 5.0 5 6.2 (1.3) [5–8]
 Muscle loss
  Lack of tone 1 5.0 1 7.0
  Muscle loss 1 3.5 4 6.0 (1.8) [4–8]
  Muscle wasting 0 NA 1 10.0
 Muscle lump 0 NA 1 6.0
 Warm/heat in upper leg; blocking spine chest part 2 8.8 (1.8) [7.5–10] 2 8.5 (2.1) [7–10]
Gastrointestinal symptoms
 Abdominal discomfort
  Poor digestion 1 8.0 1 8.0
 Abdominal pain or cramps 6 8.0 (1.4) [6–10] 8 6.4 (2.3) [3–9]
 Acid reflux 1 10.0 1 10.0
 Bloating 2 7.5 (0.7) [7–8] 1 7.0
 Constipation 2 5.0 (2.8) [3–7] 3 8.0 (2.0) [6–10]
 Diarrhea 9 7.3 (1.9) [4–9] 11 6.1 (2.8) [1–10]
 Nausea 5 7.2 (2.6) [4–10] 6 6.7 (3.4) [2–10]
 Stool changes 0 NA 1 7.0
 Vomiting 4 6.8 (2.8) [4–10] 2 7.5 (3.5) [5–10]
Cardiovascular symptoms
 Difficulty breathing 0 NA 4 9.3 (1.0) [8–10]
 Heart palpitations 1 8.5 2 7.0 (2.8) [5–9]
 Increased heart rate 1 5.0 0 NA
Cold-like symptoms
 Chills 2 7.0 (1.4) [6–8] 3 5.3 (2.1) [3–7]
 Dizziness
  Dizziness 2 8.5 (0.7) [8–9] 2 9.0 (1.4) [8–10]
  Feels faint 2 9.5 (0.7) [9–10] 1 10.0
 Feels sick or poorly 6 6.8 (1.8) [5–10] 8 6.9 (2.5) [2–10]
 Feels hot 2 7.0 (1.4) [6–8] 2 7.5 (2.1) [6–9]
 Runny or stuffy nose 3 8.7 (1.2) [8–10] 4 5.3 (3.0) [2–9]
 Sneezing 1 8.0 4 4.0 (0.8) [3–5]
 Throat symptoms
  Sore throat 5 6.5 (2.8) [3–9.5] 8 5.5 (2.7) [1–9]
Mood changes due to medication
 Anxiety
  Anxiety 12 7.8 (2.8) [1–10] 12 8.4 (1.2) [6–10]
  Nervous 0 NA 1 8.0
 Depression
  Depression 6 9.2 (1.3) [7–10] 7 7.9 (1.7) [5–10]
  Low mood 1 5.0 1 6.0
  Sadness 2 9.5 (0.7) [9–10] 3 7.7 (1.5) [6–9]
  Mood changes 0 NA 1 7.0
 Hostility or agitation 5 8.4 (2.2) [6–10] 6 6.8 (2.8) [3–10]
Cognitive and memory problems
 Cognitive symptoms
  Fuzzy thoughts 0 NA 1 9.0
  Difficulty concentrating 2 8.5 (2.1) [7–10] 6 8.8 (1.2) [7–10]
 Memory problems
  Amnesia 2 10.0 (0.0) [10] 0 NA
  Memory problems 10 7.2 (2.3) [4–10] 10 8.2 (2.1) [4–10]
Fatigue-related symptoms
 Fatigue 0 NA 15 7.1 (1.9) [3–10]
 Exhaustion 17 7.3 (1.8) [5–10] 22 7.5 (2.0) [2–10]
 Lack of energy 24 7.1 (2.2) [3–10] 26 7.4 (2.1) [2–10]
 Tiredness 24 6.7 (2.3) [3–10] 21 7.3 (2.0) [5–10]
Sensory and systems problems
 Skin and hair symptoms
  Bruising 1 2.0 1 6.0
  Eczema 0 NA 1 6.0
  Hair loss 2 9.0 (0.0) [9] 2 10.0 (0.0) [10]
  Rash 2 8.5 (2.1) [7–10] 2 10.0 (0.0) [10]
  Sensitive skin 0 NA 2 9.5 (0.7) [9–10]
  Skin ulcers 1 6.0 1 10.0
Additional symptoms
 Kidney problems
  Frequent urination 0 NA 2 7.0 (4.2) [4–10]
 Liver problems 1 8.0 2 7.0 (4.2) [4–10]
 Sweating 0 NA 2 9.0 (1.4) [8–10]
 Swelling or inflammation
  Swelling 2 9.5 (0.7) [9–10] 4 8.3 (1.7) [6–10]
 Weight-related symptoms
  Fat loss 0 NA 1 0.0
  Weight gain 1 10.0 1 10.0

n number of patients rating symptom, NA not applicable, SD standard deviation